The Pilot-to-Protocol™ Method
Most MedTech ventures don’t fail because the technology is weak. They fail because they scale before they’ve proven they should.
In MedTech, Product-Market Fit is the Foundation
In MedTech, the ultimate goal isn’t just growth. The goal is to become the protocol, the recognized standard of care on which clinicians, hospitals, and payers rely.
Product-market fit in this context means having clear, measurable evidence that your technology solves a real, urgent problem for a well-defined set of customers, and that those customers will adopt and pay for it in a repeatable, scalable way.
Unlike most B2B verticals, revenue can be an unreliable indicator of product-market fit. Early revenue from pilots, grants, or research contracts can create the appearance of traction without confirming scalable demand. At the same time, the time required to generate clinical evidence, navigate long sales cycles, and clear regulatory and Value Analysis Committee requirements means companies can make meaningful progress on real product-market fit well before revenue begins to scale. This is why we assess product-market fit across multiple metrics rather than inferring it from revenue alone.
Introducing the Pilot-to-Protocol™ methodology
It is a structured, MedTech-specific approach that begins with rigorous product-market fit diagnosis and guides companies through four deliberate stages, with the ultimate goal of becoming the industry standard of care.
The methodology was built from over a decade of operating experience scaling MedTech companies. It combines proven B2B growth principles with the specific realities of regulated healthcare markets, including long sales cycles, clinical evidence requirements, reimbursement complexity, and capital constraints. Unlike generic growth frameworks, it is designed specifically for the journey from early pilot success to sustainable, defensible scale.
Rather than prescribing a rigid sequence, the Pilot-to-Protocol™ Method helps companies accurately assess their current stage and apply the appropriate focus, tools, and discipline for where they are. This stage-appropriate approach increases the likelihood of building lasting commercial traction and ultimately becoming the recognized standard of care in their markets.
The Pilot-to-Protocol™ Method is built around two core constructs: four distinct stages of development and seven key levers of product-market fit. The stages represent the journey a MedTech venture takes from early pilot success to becoming the industry standard of care. The levers represent the critical dimensions that must be evaluated and addressed to achieve and maintain product-market fit. Rather than applying equal focus across all seven levers at all times, the methodology recognizes that their relative importance shifts depending on the company’s stage. What matters most in the Exploratory stage is different from what drives progress in the Accelerating or Commanding stages. This stage-specific focus helps leadership concentrate resources and attention where they will have the greatest impact.
Exploratory
Persona
Problem
Promise
Product
Formative
Persona
Problem
Promise
Product
Evidence Generation
Accelerating
Persona
Problem
Promise
Product
Evidence Generation
Regulatory & Reimbursement
Value Analysis Committee (VAC) Readiness
Commanding
Persona
Problem
Promise
Product
Evidence Generation at Scale
Regulatory & Reimbursement Optimization
Value Analysis Committee (VAC) Optimization
Exploratory
The Exploratory stage focuses on rigorously assessing product-market fit across the 3 primary levers (Persona, Problem & Promise) core levers and testing problem-solution fit (PSF) and problem-solution outcome (PSO) with key clinical, administrative, and operational stakeholders. The focus on Product is minimal at this point - think MVP, the minimum viable product capable of validating PSF.
Once PSF and PSO are validated - and not before - the work shifts to designing and executing well-structured pilots, with the clear goal of validating that the technology can deliver measurable value in actual clinical environments.
By the end of this stage, leadership has a clear, data-driven confirmation that a real, painful problem exists and that you are solving it for the right group of users.
Formative
The core challenge is no longer proving that a problem exists or that your solution can work in controlled conditions. Instead, the focus becomes proving that you can repeatably sell, implement, and support your solution inside real healthcare organizations.
This stage centers on crossing the Adoption Gap by building the foundational elements required for scalable growth, including refining value proposition and messaging, mapping key buyers and influencers, and establishing early evidence, regulatory, and reimbursement foundations.
Companies also begin putting in place the basic commercial processes and feedback loops needed to execute consistently.
Success at the Formative stage means you have a defined go-to-market motion and the early systems required to repeatedly sell, implement, and support your solution.
Accelerating
By the time a company reaches the Accelerating stage, the Adoption Gap has been crossed, at least in its earliest form. The core problem has been validated, early pilots have evolved into repeatable commercial activity, and the company has begun to demonstrate that its solution can be sold, implemented, and used consistently while protecting the Product-Market Fit it has built.
This stage focuses on strengthening evidence at scale, preparing for and navigating Value Analysis Committees, developing strategic health-system partnerships, and building repeatable commercial operations and data infrastructure. The company must also evolve from founder-dependent execution to team-enabled execution. Ongoing monitoring of product-market fit and responsiveness to market signals become critical as adoption expands.
By the end of this stage, the company has the partnerships, processes, and operational discipline required to scale adoption in a more repeatable and capital-efficient way.
Commanding
In reaching the Commanding stage, the company has professionalized its commercial organization, built repeatable processes, and demonstrated the ability to grow while protecting the value that created early traction.
The focus moves from building the capabilities to scale effectively to achieving sustainable category leadership, deepening competitive advantage, and driving efficient, high-margin growth with land and expand strategies, instead of relying solely on new logo acquisition.
To achieve this, the company also shifts from protecting Product-Market Fit to actively deepening and expanding it. This means not only monitoring for erosion but also finding ways to strengthen and extend Product-Market Fit across more use cases, sites, and buyer types within the installed base.
The company has the organizational strength and operational maturity to sustain its position as the recognized standard of care.
This isn’t a generic GTM playbook.
Real-world progress is rarely linear, and the Pilot-to-Protocol™ Method is not a rigid, one-size-fits-all sequence. What matters most is accurately diagnosing a company’s current stage and then applying the right focus, tools, and building the targeted disciplines to create success based on the PMF reality on the ground.
Growthplane uses the Stage/Lever matrix as a practical diagnostic and planning framework. By evaluating where a company stands across the four stages and understanding which of the seven levers require the most attention at that point, we help leadership teams focus their efforts where they will have the greatest impact. This stage-specific approach allows us to meet companies where they are and accelerate progress toward sustainable scale and category leadership.
Get the PMF Playbook Executive Summary
& Self Assessment
Want a concise overview of the Pilot-to-Protocol™ Method along with a practical self-assessment tool? Download the free Executive Summary and 7-Lever PMF Self-Assessment.
Ready to Get Started?
If you’d like to discuss where your venture stands and get personalized guidance on applying the Pilot-to-Protocol™ Method, let’s talk.